TelePeptide dispenses compounded preparations of semaglutide and tirzepatide prepared by US-licensed 503A or 503B compounding pharmacies
BMI 30 kg/m, or BMI 27 kg/m with at least one weight-related condition (e.g., hypertension, type 2 diabetes, dyslipidemia) For pediatric patients (1217 years old) 1
Tirzepatide in Sacramento Semaglutide and Tirzepatide are both effective GLP-1 receptor agonists for weight loss, but understanding their differences is vital before making a decision
References Natsch, A., & Emter, R
As a dual GIP and GLP-1 receptor agonist, it improves blood glucose control and promotes weight loss
These effects typically diminish as your body adjusts, and they can be minimized through gradual dose increases, eating smaller frequent meals, and staying hydrated